Barclays’s Fractyl Health GUTS Stock Holding History

Barclays’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.38K	Buy	670 +515	+332%	+$4.27K	﹤0.01%	4908
2026 Q2	$1.48K	Sell	155 -9,516	-98%	-$81.3K	﹤0.01%	4900
2026 Q1	$53.1K	Sell	9,671 -10,604	-52%	-$117K	﹤0.01%	4296
2025 Q4	$535K	Buy	+20,275	New	+$392K	﹤0.01%	3807
2025 Q2	–	Sell	-2,992	Closed	-$42.7K	–	5596
2025 Q1	$42.7K	Sell	2,992 -1,419	-32%	-$27.2K	﹤0.01%	4655
2024 Q4	$109K	Buy	4,411 +428	+11%	+$12K	﹤0.01%	4571
2024 Q3	$121K	Buy	3,983 +3,768	+1,753%	+$148K	﹤0.01%	4519
2024 Q2	$11K	Buy	+215	New	+$16.6K	﹤0.01%	4510

Other funds holding GUTS

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Accredited Investors Edina, Minnesota $2.33B AUM 21.62% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

R Squared Central, Hong Kong $188M AUM 18.2% 1-Year Est. Return

BWG

Boomfish Wealth Group Alpharetta, Georgia $231M AUM 21.59% 1-Year Est. Return

Brookstone Capital Management Wheaton, Illinois $10.1B AUM 17.94% 1-Year Est. Return

J.W. Cole Advisors Tampa, Florida $5.93B AUM 23.96% 1-Year Est. Return

Barclays's GUTS Position: Q3 2026 in Review

Barclays increased its Fractyl Health (GUTS) stake by 332% in Q3 2026, buying an estimated $4.27K and bringing the position to 670 shares worth $4.38K. The position accounts for ﹤0.01% of the portfolio, ranked #4908.

Barclays first reported a position in GUTS in Q2 2024 and has held it in 8 quarters since. The position peaked at $535K in Q4 2025. 21 funds tracked by Wall St. Rank hold GUTS as of Q3 2026.

Barclays held 670 shares of Fractyl Health worth $4.38K as of Q3 2026.
Barclays bought 515 Fractyl Health shares in Q3 2026, an estimated $4.27K.
Fractyl Health made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4908 holding.
Barclays first reported a position in Fractyl Health in Q2 2024 and has held it in 8 quarters since.
Barclays's Fractyl Health position peaked at $535K in Q4 2025.
21 funds tracked by Wall St. Rank held Fractyl Health as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.